Customer Service Data Entry
Resume:
**** ********** *****, *. **********, SC ***** 843-***-****
**********@*****.***
April M. Bell
Objective To obtain a position that will utilize my skills and knowledge.
Experience
**** ******t National Allergy and Asthma Centers North Charleston, SC
Clinical Research Coordinator
Obtained patient work up
Coordinated 6+ investigational drug studies for well known drug companies
Performed EKG and venipuncture
Obtained vitals and reviewed patient medication
Data Entry for all drug studies
Regulatory documents for all drug studies
Budget and Contract for all drug studies
Creation of Source Document’s for all drug studies
Correspondence and on call for all drug studies
Pharmacy & Labs & Drug for subjects on all drug studies
Accountability for study drug
Assisting in and preparing for monitoring visits from sponsors
Assisting in and preparing for Audits from sponsors
Recruitment for subjects for all drug studies
Studies I have conducted upon request
2007 2011 The Neurology and Pain Clinic Orangeburg, SC
Medical Asst., Billing Asst., Office Management Asst., Drug study Coordinator
Assist in management duties upon request per Office Manager
Obtained patient work up
Coordinated 6+ investigational drug studies for well known drug companies
Performed EKG and venipuncture when needed
Obtained vitals and reviewed patient medication
Intramuscular injections
Billing and coding per ICD 9
Data Entry for all drug studies
Regulatory documents for all drug studies
Budget and Contract for all drug studies
Creation of Source Document’s for all drug studies
Correspondence and on call for all drug studies
Pharmacy & Labs & Drug for subjects on all drug studies
Accountability for study drug
Assisting in and preparing for monitoring visits from sponsors
Assisting in and preparing for Audits from sponsors
Recruitment for subjects for all drug studies
Studies I have conducted upon request
Dec/2007 Dr.’s Care N. Charleston, SC
Medical Office Assistant,
Scheduled appointments
Checked patients in & out
Filing
Bookkeeping, and accounting
Basic receptionist duties including scheduling, answering phone, Faxing, etc.
Feb/2007 Parkwood Orthopaedic West Ashley, SC
Medical Office Assistant,
checked in patients, scheduled appointments, answered phone, filed and
pulled charts, assisted doctor with patients, daily deposits and accounting
Aug/2004 Bruns Monumental Co. Columbia, SC
Asst. Manager,
Daily Management decisions
Basic receptionist duties including scheduling, answering phone,
Faxing, etc.
Filing
Bookkeeping and Accounting
Payroll and Daily Deposit’s
Producing Sales for product
Feb/2000 Superior Honda Orangeburg, SC
Receptionist
Basic receptionist duties including scheduling, answering phone,
Faxing, etc.
Filing
Bookkeeping and Accounting
Payroll and Daily Deposit’s
Customer Service for Parts & Service Department
Education Special Skills: Cordova, SC
Windows 95, Windows 98, Windows 99, Windows XP,
Microsoft Word & Excel (93 2007 version’s)
Companion Software
Misys Software
ECW Software
High School Diploma Cordova, SC
Diploma in Education, May 1999
Cope Vocational School Cope, SC
1 yr. Completion in Health Occupations
Certificates: Orangeburg & Charleston, SC
(NIH) Protecting Human Research Participants
Completion: 8/13/2009
Certificate # 266571
Completion: 1/20/2013
Certificate # 1084365
eResearch Technology, Inc.
ECG Certificate (PAT100)
Completion: 9/15/2009
eResearch Technology, Inc.
ECG Certificate Mortara ELI 150 RX (EQP108)
Completion: 9/15/2009
Quintiles QECG
ELI 250 Electrocardiograph Certificate
Completion: 4/07/2010
Credentialing Insurance
Completion: 5/23/2011
Certificate # 123367
Compliance Fraud, Waste and Abuse Training Insurance
Completion: 5/13/2011
Certificate # 921560
Good Clinical Practice updated
Completion: 12/19/2011
Adult, Child, Infant CPR/AED Certificate
Completion: 12/30/2012
Expires: 12/30/2014
ID# A454605
Certificates of Attendance: Orangeburg, SC
Continuing Education Credits
Consortium for Advancements in Health & Human Services
1 HR Completion: 12/15/2010
Code: CM2050
Certificate # A203
Expires: 10/31/2012
1 HR Completion: 1/06/2011
Code: CM2050
Certificate # A205
Expires: 10/31/2012
1 HR Completion: 1/20/2011
Code: CM2050
Certificate # A206
Expires: 10/31/2012
1 HR Completion: 2/03/2011
Code: CM2050
Certificate # A201
Expires: 10/31/2012
1 HR Completion: 3/24/2011
Code: CM2050
Certificate # A211
Expires: 10/31/2012
Skills Working knowledge of computers, copier, fax machine, and other basic office equipment.
Excellent organizational communication, interpersonal and time management skills. Strong
work ethic, highly motivated self starter dedicated to quality service.
Study Drug: Lyrica DPN / Sponsor: Pfizer
Drug Study
Protocol: A0081242 / Diabetic Peripheral Neuropathy
Participation
Study Drug: Vanquix Auto Injector / Sponsor: King Pharmaceuticals
Protocol: K826 05 3001 / Seizure Study
Study Drug: Dimebon / Sponsor: Pfizer
Protocol: B1451027 B1451029 / Alzheimer
Study Drug: DPN / Sponsor: Pfizer
Protocol: A4091031 / Diabetic Peripheral Neuropathy
Study Drug: Vimpat / Sponsor: Schwarz Biosciences, Inc.
Protocol: UCB SP954 / Uncontrollable Seizures
Study Drug: Tanezumab / Sponsor: Pfizer
Protocol: A4091030 / Osteoarthritis
Study Drug: Latrepirdine / Sponsor: Pfizer
Protocol: B1451051 Alzheimer
Study Drug: Carisbamate, Topiramate, Levetiracetam
Sponsor: Ortho McNeil Janssen Scientific Affairs, LLC.
Protocol: Caripsepy 3007 / Partial Onset Seizures
A Randomized, Double and Evaluator Blinded, Ac tive and Placeo
Con trolled, Three Arm, Parallel, 12 Week Study in Adolescent and
Adult Patients with Asthma
Evaluation of Efficacy and Safety of XXX in Children with Asthma
(A Randomized, Double Blind, Placebo Controlled, Two Arm,
Parallel, 4 Week Study in 4 11 Year Old Children with Asthma)
A 3 Month Safety Evaluation Extension to the 12 Week XXX Study in Asthma Patien ts:
A Double Blinded, Placebo Controlled, Parallel, 3 Month Safety in Adolescent and Adult
Patients with Asthma
A 28 Day Study Evaluating the Safety of Ragweed (Ambrosia artemisiifolia) Allergy
Immunotherapy Tablet (SCH 39641/MK 3641) Treatment in Ragweed Allergic Adults
A phase III, multicenter, randomized, double blind, placebo controlled, dose ranging study
to evaluate the efficacy and safety of XXX in patients with chronic idiopathic urticarial
(CIU) who remain symptomatic despite antihistamine treatment (H1)
A randomized, placebo controlled, dose ranging, multi center trial of QAW039 (1 450 mg
p.o.) to investigate the effect on FEV1 and ACQ in patients with moderate to severe,
persistent allergic asthma, inadequately controlled with ICS therapy
A 12 Week Dose ranging Study to Evaluate the Efficacy and Safety of XXX Administered
Twice Daily Compared with Placebo in Adolescent and Adult Subjects with Persistent
Asthma Uncontrolled on Non steroidal Therapy
A Phase 2b, Dose ranging Study to Evaluate the Efficacy and Safety of XXX in Adults with
Uncontrolled Asthma
A 12 Week Randomized, Double Blind, Placebo Controlled, Parallel Group, Safety and
Efficacy Study of XXX Nasal Aerosol in Subjects 6 11 Years with Perennial Allergic Rhinitis
Psychometric Validation of an Asthma Symptom Diary in Adolescent and Adult Patients
with Persistent Asthma
A 12 week, double blind, randomized, multi center, parallel group study evaluating the
efficacy safety, and patient use (User Study) of XXX twice daily compared with XXX AC
(actuation counter) twice daily and XXX twice daily in adult and adolescent asthmatics
A 26 week, randomized, double blind, parallel group, active controlled, multicenter,
multinational safety study evaluating the risk of serious asthma related events during
treatment with XXX, a fixed combination of inhaled corticosteroid XXX and a long acting
B2 agonist (LABA) XXX as compared to treatment with ICS XXX alone in adult and
adolescent (> 12 years of age) patients with asthma
A Phase III, multicenter, randomized, double blind, placebo controlled safety study of XXX
in patients with chronic idiopathic urticarial (CIU) who remain symptomatic despite
treatment with H1 antihistamines, H2 blockers, and/or leukotriene receptor antagonists
A dose ranging study of XXX inhalation powder in children aged 5 11 years with asthma
on a background of inhaled corticosteroid therapy
A dose ranging study of XXX inhalation powder in children age 5 11 years with asthma
A randomized, double and evaluator blinded, active and placebo controlled, three arm,
parallel, 12 week study in adolescent and adult patients with asthma
A 3 month safety evaluation extension to the 12 week study in asthma patients (A double
blinded, placebo controlled, parallel, 3 month safety study in adolescent and adult patients
with asthma)
Evaluation and efficacy and safety of in children with asthma (A randomized, double blind,
placebo controlled, two arm, parallel, 4 week study in 4 11 year old children with asthma)
Contact this candidate